BeStock  
Stocks › Biotechnology › ANNX

Annexon ANNX

US equityMarket cap rank #3449Biotechnology
$4.01 −$0.02 (-0.50%)
Market closed · Oct 8, 7:20 am ET · Last extended-hours $4.05 +1.00%
Open$3.99
Prev close$4.03
Day range$3.91 – $4.18
Volume2.45M
Market cap$760.21M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-3.5x
CheapRich

Below its usual level · 34th percentile, 5-year average -2.9x

Price / book4.1x
CheapRich

Near the top of its 5-year range · 85th percentile, 5-year average 1.9x

#4070 of 5317 stocks by PB (1 = cheapest)

P/E over five years

-10x-7x-3x0xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$4.41
Price vs. fair value-9.0%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 4.09 – 1.94 85% (pricier than usual) #4070 of 5317 (1 = cheapest)
PE -3.55 -3.28 -2.93 34% (cheaper than usual) –
PS – 69.67 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$4.41
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on ANNX.

Leave a comment

Scroll to Top